Point72 »

Arcutis Biotherapeutics shares owned by Point72

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $25k 2.7k 9.30

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
BlackRock
Vanguard Group
State Street Corporation
Franklin Resources
Morgan Stanley
Citadel Advisors
Cormorant Asset Management
Geode Capital Management
Ensign Peak Advisors
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics